Intercept Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

23,834

Value ($000)

442

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	442	0.0%	23,834	9/30/2023
2023 Q2	8/11/2023	320	0.0%	23,834	6/30/2023
2023 Q1	5/15/2023	320	0.0%	23,834	3/31/2023
2022 Q4	2/14/2023	341	0.0%	27,579	12/31/2022
2022 Q3	11/14/2022	176	0.0%	12,631	9/30/2022
2022 Q2	8/12/2022	323	0.0%	23,423	6/30/2022
2022 Q1	5/16/2022	409	0.0%	25,109	3/31/2022
2021 Q4	2/14/2022	409	0.0%	25,109	12/31/2021
2021 Q3	11/15/2021	373	0.0%	25,109	9/30/2021
2021 Q2	8/16/2021	501	0.0%	25,109	6/30/2021
2021 Q1	5/14/2021	292	0.0%	12,631	3/31/2021
2020 Q4	3/1/2021	312	0.0%	12,631	12/31/2020
2020 Q3	11/13/2020	6,655	0.0%	160,516	9/30/2020
2020 Q2	8/14/2020	7,966	0.0%	166,266	6/30/2020
2020 Q1	5/15/2020	10,609	0.0%	168,509	3/31/2020
2019 Q4	2/14/2020	22,703	0.0%	183,205	12/31/2019
2014 Q1	5/23/2014	27,109	0.0%	82,200	3/31/2014
2013 Q4	1/31/2014	7,408	0.0%	108,500	12/31/2013